GDPR has significant implications for cancer research. Researchers often need to handle sensitive data, including genetic and health information. Under GDPR, such data is classified as special category data, requiring additional safeguards to ensure its protection. Researchers must obtain explicit consent from patients to use their data and must provide clear information about how the data will be used, stored, and shared.
